Development and characterization of a luminescence-based high-throughput serum bactericidal assay (l-sba) to assess bactericidal activity of human sera against nontyphoidal salmonella

HIGHLIGHTS

• who: Maria Grazia Aruta and collaborators from the GSK Vaccines Institute for Global Health Srl, Via Fiorentina, Siena, Italy Pathology Department, Kamuzu University of Health Sciences, have published the Article: Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay (L-SBA) to Assess Bactericidal Activity of Human Sera against Nontyphoidal Salmonella, in the Journal: (JOURNAL)
• what: Written informed consent was obtained before enrollment from all subjects, and the trial was designed and conducted in accordance with the Good Clinical Practice Guidelines and the Declaration of Helsinki. In this work, the L-SBA . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.